Cardiac magnetic resonance in patients with muscular dystrophies: strengthening the data

Emery AE. The muscular dystrophies. Lancet 2002; 359: 687–695.

Mercuri E Bonnemann CG Muntoni F. Muscular dystrophies. Lancet 2019; 394: 2025–2038.

Ashizawa T Gagnon C Groh WJ , et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract 2018; 8: 507–520.

Aimo A Giannoni A Castiglione V , et al. Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease. Eur J Prev Cardiol 2017; 24: 1718–1724.

Palladino A D’Ambrosio P Papa AA , et al. Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms. Acta Myol 2016; 35: 128–134.

Aimo A Emdin M. Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease. Eur J Prev Cardiol 2017; 24: 1727–1728.

Frankel KA Rosser RJ. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 1976; 7: 375–386.

Melacini P Fanin M Danieli GA , et al. Myocardial involvement is very frequent among patients affected with subclinical Becker’s muscular dystrophy. Circulation 1996; 94: 3168–3175.

Mercuri E Muntoni F. Muscular dystrophies. Lancet 2013; 381: 845–860.

Hor KN Wansapura J Markham LW , et al. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 2009; 53: 1204–1210.

Grigoratos C Aimo A Barison A , et al. Cardiac magnetic resonance in patients with muscular dystrophies. Eur J Prev Cardiol. Epub ahead of print 16 May 2020. DOI: 10.1177/2047487320923052.

Verhaert D Richards K Rafael-Fortney JA , et al. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging 2011; 4: 67–76.

Feingold B Mahle WT Auerbach S , et al. Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association. Circulation 2017; 136: e200–e231.

McNally EM Mann DL Pinto Y , et al. Clinical care recommendations for cardiologists treating adults with myotonic dystrophy. J Am Heart Assoc 2020; 9: e014006.

Schoser B Montagnese F Bassez G , et al. Consensus-based care recommendations for adults with myotonic dystrophy type 2. Neurol Clin Pract 2019; 9: 343–353.

Menacho-Medina K Ntusi NAB Moon JC , et al. Rapid cardiac MRI protocols: feasibility and potential applications. Curr Radiol Rep 2020; 8: 2.

Captur G Lobascio I Ye Y , et al. Motion-corrected free-breathing LGE delivers high quality imaging and reduces scan time by half: an independent validation study. Int J Cardiovasc Imaging 2019; 35: 1893–1901.

Holst K Ugander M Sigfridsson A. Left ventricular volume measurements with free breathing respiratory self-gated 3-dimensional golden angle radial whole-heart cine imaging – feasibility and reproducibility. Magn Reson Imaging 2017; 43: 48–55.

Nacif MS Zavodni A Kawel N , et al. Cardiac magnetic resonance imaging and its electrocardiographs (ECG): tips and tricks. Int J Cardiovasc Imaging 2012; 28: 1465–1475.

Unterberg-Buchwald C Fasshauer M Sohns JM , et al. Real time cardiac MRI and its clinical usefulness in arrhythmias and wall motion abnormalities. J Cardiovasc Magn Reson 2014; 16 (Suppl. 1): P34.

The Royal College of Radiologists. Guidance on gadolinium-based contrast agent administration to adult patients, 2019. https://www.rcr.ac.uk/system/files/publication/field_publication_files/bfcr193-gadolinium-based-contrast-agent-adult-patients.pdf (2019; accessed 26 May 2020).

Bhuva AN Moralee R Moon JC , et al. Making MRI available for patients with cardiac implantable electronic devices: growing need and barriers to change. Eur Radiol 2020; 30: 1378–1384.

Olivieri LJ Cross RR O’Brien KE , et al. Optimized protocols for cardiac magnetic resonance imaging in patients with thoracic metallic implants. Pediatr Radiol 2015; 45: 1455–1464.